Stifel analyst Adam Borg downgrades Ping Identity Holding (NYSE:PING) from Buy to Hold.
Gracell Biotechnologies To Present Updated Results From BCMA/CD19 Dual-Targeting FasTCAR-T GC012F In Newly Diagnosed Multiple Myeloma At The 65 American Society Of Hematology Annual Meeting & Exposition
Oral presentation of the updated results from ongoing Phase 1 investigator-initiated study of GC012F in frontline setting for transplant-eligible, high-risk newly diagnosed multiple myeloma GC012F is a
